Skip to main content
Premium Trial:

Request an Annual Quote

SomaLogic to Conduct Aptamer Feasibility Study with Beckman Coulter

NEW YORK, July 23 - SomaLogic said today it has signed an agreement with Beckman Coulter to conduct a feasibility study on the integration of its aptamer technology with Beckman Coulter's liquid handling workstation and plate and array reader platforms.

 

Under the agreement, SomaLogic, of Boulder, Colo., will work with Beckman Coulter's Advanced Technology Center, which evaluates technologies as to their usefulness in future products.

 

"We are pleased to be working together to develop new approaches for array-based quantitative proteomics," stated Keith Warner SomaLogic's chief business officer. "We look forward to the possibility of creating next- generation products that combine our aptamers with Beckman Coulter's industry- leading fluid handling systems and innovative array technologies."

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.